These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27746395)

  • 1. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
    Montravers P; Perrigault PF; Timsit JF; Mira JP; Lortholary O; Leroy O; Gangneux JP; Guillemot D; Bensoussan C; Bailly S; Azoulay E; Constantin JM; Dupont H;
    Clin Microbiol Infect; 2017 Feb; 23(2):117.e1-117.e8. PubMed ID: 27746395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.
    Montravers P; Mira JP; Gangneux JP; Leroy O; Lortholary O;
    Clin Microbiol Infect; 2011 Jul; 17(7):1061-7. PubMed ID: 20825438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
    Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF
    Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
    Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
    J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit.
    Pagès A; Iriart X; Molinier L; Georges B; Berry A; Massip P; Juillard-Condat B
    Value Health; 2017 Dec; 20(10):1319-1328. PubMed ID: 29241891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
    Leroy O; Bailly S; Gangneux JP; Mira JP; Devos P; Dupont H; Montravers P; Perrigault PF; Constantin JM; Guillemot D; Azoulay E; Lortholary O; Bensoussan C; Timsit JF;
    Ann Intensive Care; 2016 Dec; 6(1):2. PubMed ID: 26743881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
    Li WS; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):370-376. PubMed ID: 26321461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of real life treatment strategies for Candida peritonitis-A retrospective analysis.
    Dubler S; Laun M; Koch C; Hecker A; Weiterer S; Siegler BH; Röhrig R; Weigand MA; Lichtenstern C
    Mycoses; 2017 Jul; 60(7):440-446. PubMed ID: 28370502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective analysis of invasive candidiasis following cardiac surgery: severity markers are predictive.
    Forstner C; Lassnigg A; Tobudic S; Schiferer A; Fischer H; Graninger W; Steinlechner B; Frantal S; Presterl E
    J Infect; 2013 Jun; 66(6):528-35. PubMed ID: 23438944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole].
    Yamagishi Y; Terada M; Ohki E; Mikamo H
    Jpn J Antibiot; 2009 Oct; 62(5):415-34. PubMed ID: 20055119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antifungal treatment for suspected or proved candidiasis in the critically ill].
    Massanet P; Jung B; Molinari N; Villiet M; Moulaire V; Roch-Torreilles I; Jaber S; Reynes J; Corne P
    Ann Fr Anesth Reanim; 2014 Apr; 33(4):232-9. PubMed ID: 24684836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida as a risk factor for mortality in peritonitis.
    Montravers P; Dupont H; Gauzit R; Veber B; Auboyer C; Blin P; Hennequin C; Martin C
    Crit Care Med; 2006 Mar; 34(3):646-52. PubMed ID: 16505648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Candida infections in patients of a medical intensive care unit: attempt of improving diagnosis by quantifying the colonization.
    Kautzky S; Staudinger T; Presterl E
    Wien Klin Wochenschr; 2015 Feb; 127(3-4):132-42. PubMed ID: 25412592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines.
    Tsuruta R; Mizuno H; Kaneko T; Oda Y; Kaneda K; Fujita M; Inoue T; Kasaoka S; Maekawa T
    Ann Pharmacother; 2007 Jul; 41(7):1137-43. PubMed ID: 17535843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU.
    Bruyère R; Quenot JP; Prin S; Dalle F; Vigneron C; Aho S; Leon C; Charles PE
    BMC Infect Dis; 2014 Jul; 14():385. PubMed ID: 25015848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors affecting costs in patients receiving systemic antifungal therapy in intensive care units in Greece: Results from the ESTIMATOR study.
    Armaganidis A; Nanas S; Antoniadou E; Mandragos K; Liakou K; Koutsoukou A; Baltopoulos G; Nakos G; Kounougeri A; Ganas K; Prekates A; Kompoti M; Georgopoulos D; Pneumatikos I; Zakynthinos E
    Mycoses; 2017 Jul; 60(7):454-461. PubMed ID: 28425571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe case of Candida peritonitis in a patient on CAPD--a successful treatment].
    Hennings L; Bouchard R; Klempien I; Müller G; Rob P; Kujath P
    Mycoses; 2005; 48 Suppl 1():78-83. PubMed ID: 15826293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
    Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
    JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.